Home Minerva Biotechnologies Granted Worldwide License To iPS Technology
 

Keywords :   


Minerva Biotechnologies Granted Worldwide License To iPS Technology

2015-08-05 06:57:21| drugdiscoveryonline Home Page

Minerva Biotechnologies and iPS Academia Japan, Inc. announced recently that they have signed an agreement granting Minerva worldwide rights to use and commercialize the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work of Professor Shinya Yamanaka, MD, Ph.D., who won the Nobel Prize for Medicine in 2012 for his discovery of four genes that can reprogram an adult’s cell to go back in time to become that person’s own stem cell

Tags: technology license worldwide granted

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11AKB48 1st
14.11kindle 10
14.11
14.11YAMAHA PORTATONE PSR-340
14.112003 112
14.11 14533.5
14.11caligari 17
14.11 amnjx 27circus
More »